Development and Validation of a Digital Optotype for Near Vision in Greek Language.
DeDART
1 other identifier
observational
100
1 country
1
Brief Summary
Primary objective of our study is to develop and validate a computer-based digital near-vision optotype based on the Greek version of the print MNREAD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 28, 2019
CompletedFirst Submitted
Initial submission to the registry
January 8, 2020
CompletedFirst Posted
Study publicly available on registry
January 27, 2020
CompletedJanuary 27, 2020
January 1, 2020
3 months
January 8, 2020
January 24, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Reading Acuity (RA)
The smallest print that the patient can read without making significant errors, and can be calculated by the following formula: Acuity (in logMAR)= 1.4 - (sentences x 0.1) + (errors x 0.01).
through study completion, an average of 8 months
Maximum Reading Speed (MRS)
The patient's reading speed when reading is not limited by print size , and is calculated by averaging the speed of the sentences with print size larger than the CPS. \[(in words per minute (wpm)\]
through study completion, an average of 8 months
Critical Print Size (CPS)
The smallest print size at which patients can read with their MRS, and is identified as the print size of the sentence fulfilling this criterion: all of the following sentences are read at a speed that is 1.96 times the standard deviation below the average of the larger preceding sentences (that is the MRS). In other words, it is defined as the smallest print size that yields 90% of the MRS \[(in logMAR)\]
through study completion, an average of 8 months
Accessibility Index (ACC)
The mean reading speed measured across the 10 largest print sizes (1.3 to 0.4 logMAR) of the MNREAD Acuity Chart at 40 cm normalized by 200 wpm, which was the mean value for a group of 365 normally sighted young adults aged 18 to 39 years old.
through study completion, an average of 8 months
Secondary Outcomes (2)
Intraclass Correlation Coefficients (ICCs) for study participants
through study completion, an average of 8 months
Test-retest Intraclass Correlation Coefficients (ICCs)
through study completion, an average of 8 months
Study Arms (2)
Control group
1. 70 patients with normal vision (NVG) with adequate literacy of written Greek language 2. 30 patients with low vision (LVG) with adequate literacy of written Greek language These patients are tested on the printed Greek MNREAD
Study group
The same patients as those in the control group (NVG, LVG) are tested on the digital version of the Greek MNREAD (DeDART)
Interventions
One randomly selected eye is included for each study participant. Participants respond to the near vision chart with defined environmental circumstances at 40cm viewing distance. All four parameters (RA, MRS, CPS and ACC) are evaluated.
Eligibility Criteria
Normal- and low-sighted participants aged 18 to 75 years
You may qualify if:
- adequate literacy of written Greek language
You may not qualify if:
- dyslexia
- attention-deficiency
- former diagnosis of mental diseases
- former diagnosis of psychiatric diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Alexandroupolis
Alexandroupoli, Evros, 68100, Greece
Related Publications (1)
Labiris G, Panagiotopoulou EK, Chatzimichael E, Tzinava M, Mataftsi A, Delibasis K. Introduction of a digital near-vision reading test for normal and low vision adults: development and validation. Eye Vis (Lond). 2020 Oct 22;7:51. doi: 10.1186/s40662-020-00216-0. eCollection 2020.
PMID: 33102611DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Georgios Labiris, MD, PhD
University Hospital of Alexandroupolis, Alexandroupolis, Greece
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 15 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Ophthalmology
Study Record Dates
First Submitted
January 8, 2020
First Posted
January 27, 2020
Study Start
March 28, 2019
Primary Completion
June 28, 2019
Study Completion
November 28, 2019
Last Updated
January 27, 2020
Record last verified: 2020-01